16.40
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SRPT?
Forum
Prognose
Aktiensplit
Finanzdaten der Sarepta Therapeutics Inc-Aktie (SRPT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
10.91%
442.93
|
399.36 | 611.09 | 744.86 | 658.41 |
| Cost Of Revenue |
162.11%
472.04
|
180.09 | 250.53 | 270.90 | - |
| Gross Profit |
113.27%
-29.10
|
219.27 | 360.56 | 473.96 | - |
|
|
64.90%
829.02
|
502.75 | 495.51 | 1,045.24 | 496.73 |
| Interest Income/Expense |
2,207%
-40.04
|
1.90 | 5.228 | -4.503 | -32.31 |
| Benefits Costs and Expenses |
-
|
- | - | - | 486.67 |
| Costs And Expenses |
100.00%
-
|
502.75 | 495.51 | 1,045.24 | 496.73 |
| Operating Income/Loss |
298.09%
-411.58
|
-103.39 | 115.58 | -300.39 | 161.68 |
| Nonoperating Income/Loss |
247.02%
133.29
|
-90.66 | 38.06 | -83.13 | 10.06 |
| Income/Loss From Continuing Operations Before Tax |
328.26%
442.93
|
-194.05 | 153.64 | -383.52 | 171.74 |
| Income Tax Expense/Benefit |
132.27%
4.551
|
-14.10 | -43.25 | 63.99 | 12.69 |
| Income/Loss From Continuing Operations After Tax |
715.19%
-412.23
|
-50.57 | 196.89 | -447.51 | 159.05 |
|
|
715.19%
-412.23
|
-50.57 | 196.89 | -447.51 | 159.05 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
98.43%
1.575
|
100.24 | 98.00 | 97.36 | 0.406 |
| Diluted Average Shares |
98.43%
1.575
|
100.24 | 106.62 | 97.36 | 8.303 |
| Basic Earnings Per Share |
686.00%
-3.93
|
-0.50 | 2.01 | -4.60 | 1.67 |
| Diluted Earnings Per Share |
686.00%
-3.93
|
-0.50 | 1.89 | -4.60 | 1.56 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):